NASDAQ
Calidi Biotherapeutics, Inc. (CLDI) has a interest coverage ratio of -97.78x as of Friday, May 29, 2026. This represents a 101.06% decrease compared to its 12-month average of -48.63x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.